SCHEMBL491664

SCHEMBL491664

CCOC(=O)C(C#N)(Cc1ccccc1)N=Nc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.42
MAPT P10636 5/20 0.42
MEN1 O00255 3/20 0.42
AR P10275 3/20 0.40
RAB9A P51151 3/20 0.39
HPGD P15428 1/20 0.39
ALDH1A1 P00352 5/20 0.39
RECQL P46063 1/20 0.39
MMP8 P22894 1/20 0.39
MAPK1 P28482 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
PPARD Q03181 2/20 0.38
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL491661 1.00 KMT2A (0.42) KMT2AMAPTMEN1ARRAB9A
SCHEMBL491662 0.96 MAPT (0.40) KMT2AMAPTMEN1ARRAB9A
SCHEMBL5353007 0.86 ALDH1A1 (0.41) KMT2AMAPTMEN1RAB9AALDH1A1
SCHEMBL5353013 0.86 ALDH1A1 (0.41) KMT2AMAPTMEN1RAB9AALDH1A1
SCHEMBL5353011 0.82 PPARD (0.40) KMT2AMAPTMEN1RAB9AALDH1A1
SCHEMBL11553165 0.81 MLYCD (0.43) ALDH1A1RECQLMMP8MAPK1LMNA
SCHEMBL11553160 0.81 MLYCD (0.43) ALDH1A1RECQLMMP8MAPK1LMNA
SCHEMBL28796335 0.79 AR (0.44) KMT2AMAPTARRAB9AHPGD
SCHEMBL28596819 0.79 MAPT (0.39) KMT2AMAPTMEN1ARRAB9A
SCHEMBL7139929 0.75 ALDH1A1 (0.49) KMT2AARRAB9AHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7652128-B2 Toner composition XEROX CORPORATION (US) 2010-01-26 US claimed
US-20090142692-A1 LOW MOLECULAR WEIGHT LATEX AND TONER COMPOSITIONS COMPRISING THE SAME XEROX CORPORATION (US) 2009-06-04 US claimed
US-20060286476-A1 manufactured under monomer-starved polymerization condition such as monomer feeding rate equal to or less than 0.516% per minute by weight of the monomer(s) to be fed; gloss, fusing performance, crease performance, stripping performance, document offset, vinyl offset, and parent charging etc. XEROX CORPORATION 2006-12-21 US claimed
US-20060100300-A1 Toner composition XEROX CORPORATION 2006-05-11 US claimed
EP-4045544-B1 SUPER ADVANCED CONTROLLED RADICAL POLYMERIZATION BASF COATINGS GMBH (DE) 2026-03-18 EP disclosed
US-12534561-B2 Controlled radical polymerization BASF COATINGS GMBH (DE) 2026-01-27 US disclosed
US-20260002044-A1 RESIN COMPOSITION FOR SEALING MATERIAL, SEALING MATERIAL INCLUDING RESIN COMPOSITION, AND SOLID POLYMER FUEL CELL AND WATER ELECTROLYZER INCLUDING SEALING MATERIAL PANAC CO LTD (JP) 2026-01-01 US disclosed
EP-4498456-A1 RESIN COMPOSITION FOR SEALING MATERIAL, SEALING MATERIAL USING SAID RESIN COMPOSITION, AND SOLID POLYMER FUEL CELL AND WATER ELECTROLYSIS DEVICE USING SAID SEALING MATERIAL Panac Co., Ltd. (JP) 2025-01-29 EP disclosed
US-20240294689-A1 SUPER ADVANCED CONTROLLED RADICAL POLYMERIZATION BASF COATINGS GMBH (DE) 2024-09-05 US disclosed
US-20240153687-A1 COMPOSITION HAVING MAGNETOSTRICTIVE PROPERTIES, AND CURED PRODUCT THEREOF TOHOKU UNIVERSITY (JP) 2024-05-09 US disclosed
EP-4303244-A1 COMPOSITION HAVING MAGNETOSTRICTIVE PROPERTIES, AND CURED PRODUCT THEREOF TOKYO OHKA KOGYO CO., LTD. (JP) 2024-01-10 EP disclosed
CN-107526256-B Toner compositions with anti-plasticizers 施乐公司 2023-04-07 CN disclosed
US-20040152004-A1 Toner having specific relation between absorption soectra, and developer, image forming method and image forming apparatus using same FUJI XEROX CO., LTD. (JP) 2004-08-05 US disclosed
US-6607864-B2 Heating heating member that is in contact with a toner image to fix toner image onto a recording medium, wherein a surface of heating member or vicinity generates heat, and a toner forming the toner image contains a colorant and binder resin FUJI XEROX CO., LTD. (JP) 2003-08-19 US disclosed
US-6582867-B2 A crystalline binder resin and a fatty acid ester or a resin having a contact angle with water that is smaller than that of the crystalline resin; electrography; reproducibility in particle size/distribution; low-temperature fixing; stability FUJI XEROX CO., LTD. (JP) 2003-06-24 US disclosed
US-20030027073-A1 Image forming method FUJI XEROX CO., LTD. (JP) 2003-02-06 US disclosed
US-20020055050-A1 Toner for developing electrostatic latent image, process for producing the same, and process for forming image FUJI XEROX CO., LTD. (JP) 2002-05-09 US disclosed
EP-0490269-B1 Graft copolymer and process for producing the same IDEMITSU KOSAN CO (JP) 1996-02-28 EP disclosed
US-5250629-A Graft polymerization of styrene and ethylenically unsaturated monomer using transition metal catalysts, organoaluminum compounds; films, packaging, automobile parts IDEMITSU KOSAN CO., LTD. (JP) 1993-10-05 US disclosed
EP-0490269-A1 Graft copolymer and process for producing the same IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-06-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534561-B2 Controlled radical polymerization TST, G6PD, PROC KMT2A 1172/4885MAPT 1677/4885MEN1 4868/4885
US-20260002044-A1 RESIN COMPOSITION FOR SEALING MATERIAL, SEALING MATERIAL INCLUDING RESIN COMPOSITION, AND SOLID POLYMER FUEL CELL AND WATER ELECTROLYZER INCLUDING SEALING MATERIAL GJA1, ERCC1, ASH2L KMT2A 980/4885MAPT 2697/4885MEN1 3465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.